APA (7th ed.) Citation

Gong, J., Liu, T., Fan, Q., Bai, L., Bi, F., Qin, S., . . . Wang, J. (2016). Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial. BMC Cancer, 16, 1. https://doi.org/10.1186/s12885-016-2092-9

Chicago Style (17th ed.) Citation

Gong, Jifang, et al. "Optimal Regimen of Trastuzumab in Combination with Oxaliplatin/ Capecitabine in First-line Treatment of HER2-positive Advanced Gastric Cancer (CGOG1001): A Multicenter, Phase II Trial." BMC Cancer 16 (2016): 1. https://doi.org/10.1186/s12885-016-2092-9.

MLA (9th ed.) Citation

Gong, Jifang, et al. "Optimal Regimen of Trastuzumab in Combination with Oxaliplatin/ Capecitabine in First-line Treatment of HER2-positive Advanced Gastric Cancer (CGOG1001): A Multicenter, Phase II Trial." BMC Cancer, vol. 16, 2016, p. 1, https://doi.org/10.1186/s12885-016-2092-9.